Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection
- PMID: 37009541
- PMCID: PMC9954776
- DOI: 10.1177/24741264221116487
Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection
Abstract
Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.
Keywords: endophthalmitis; intravitreal injection; vascular endothelial growth factor.
© The Author(s) 2022.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
-
- Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol. 1995;113(12):1479-1496. - PubMed
